GetTopicDetailResponse(id=07c524641e, topicName=AMX0035, introduction=AMX0035, content=null, image=null, comments=2, allHits=1713, url=https://h5.medsci.cn/topic?id=2464, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=95212, tagList=[TagDto(tagId=95212, tagName=AMX0035)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2092799, encodeId=19952092e99cc, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批準<a href='/topic/show?id=5e106628237' target=_blank style='color:#2F92EE;'>#漸凍癥#</a>治療新藥——<a href='/topic/show?id=07c524641e' target=_blank style='color:#2F92EE;'>#AMX0035#</a>（<a href='/topic/show?id=b5c210486843' target=_blank style='color:#2F92EE;'>#Relyvrio#</a>，<a href='/topic/show?id=70ec104869a7' target=_blank style='color:#2F92EE;'>#苯丁酸鈉#</a>和<a href='/topic/show?id=a61b1048e099' target=_blank style='color:#2F92EE;'>#?；撬岫?</a>復(fù)方制劑）上市。<a href='/topic/show?id=d1948106eeb' target=_blank style='color:#2F92EE;'>#肌萎縮性脊髓側(cè)索硬化癥#</a>, objectTitle=FDA批準漸凍癥治療新藥——AMX0035（Relyvrio，苯丁酸鈉和?；撬岫紡?fù)方制劑）上市, objectType=article, longId=741840, objectId=b3cfe4184099, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220927/2c0e95c696c7402f8d72764d46023863.jpg, objectUrl=/article/show_article.do?id=b3cfe4184099, replyNumber=0, likeNumber=189, createdTime=2022-10-10, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3cfe4184099, moduleTitle=FDA批準漸凍癥治療新藥——AMX0035（Relyvrio，苯丁酸鈉和牛磺酸二醇復(fù)方制劑）上市, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b3cfe4184099)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943440, encodeId=a7d5194344067, content=<a href='/topic/show?id=07c524641e' target=_blank style='color:#2F92EE;'>#AMX0035#</a>, objectTitle=AMX0035治療ALS的CENTAUR II期研究已完成患者入組, objectType=article, longId=180632, objectId=6e4f18063242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e4f18063242, replyNumber=0, likeNumber=111, createdTime=2020-01-18, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e4f18063242, moduleTitle=AMX0035治療ALS的CENTAUR II期研究已完成患者入組, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6e4f18063242)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
